PATHOGENIC MECHANISMS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

被引:0
|
作者
REYESTERAN, G [1 ]
VARELA, JA [1 ]
机构
[1] NATL AUTONOMOUS UNIV MEXICO, INST NACL NUTR SALVADOR ZUBIRAN, DEPT INFECTOL, MEXICO CITY 04510, DF, MEXICO
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 1994年 / 46卷 / 02期
关键词
HIV; AIDS; IMMUNOPATHOGENIC MECHANISMS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The immunopathogenic mechanisms of the human immunodeficiency virus infection and the precise events that are involved in the clinical latency period are extremely complex and remain unknown. Thus, at the present time, there is no way to prevent or revert the disease, though several and innovative forms of treatment have been developed and different clinical trials on immunization have been conducted. In this review, we describe the molecular biology of HIV-1, the dynamic interactions between HIV and the host, particularly in the clinical latency period, and the factors that induce viral expression. The consequences of HIV infection are influenced by the immunological state of the host, especially by the subtype 1 of CD4+ T cells. The subsequent reaction of the host immune system, with neutralizing antibodies and strong CD8+ T cells response, contain temporarily the course of HIV infection. However, the HIV generates strategies in order to face, evade, and destroy direct or indirectly the immune system. The virus is then activated and replicates without control, producing the progression to AIDS, and inevitably leading to the death. Only the understanding of the pathogenic mechanisms could offer definitive alternative treatment or control of HIV infection.
引用
收藏
页码:113 / 147
页数:35
相关论文
共 50 条
  • [1] MECHANISMS OF CYTOPENIA IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    HARBOL, AW
    LIESVELD, JL
    SIMPSONHAIDARIS, PJ
    ABBOUD, CN
    BLOOD REVIEWS, 1994, 8 (04) : 241 - 251
  • [2] MOLECULAR MECHANISMS FOR THE CONTROL OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    CHANDRA, P
    CHANDRA, A
    DEMIRHAN, I
    GERBER, T
    PHARMACOLOGY & THERAPEUTICS, 1990, : 25 - 46
  • [3] IMMUNOPATHOGENIC MECHANISMS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    FAUCI, AS
    SCHNITTMAN, SM
    POLI, G
    KOENIG, S
    PANTALEO, G
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (08) : 678 - 693
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    EICKHOFF, TC
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) : 963 - 973
  • [5] SEIZURES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    WONG, MC
    SUITE, NDA
    LABAR, DR
    ARCHIVES OF NEUROLOGY, 1990, 47 (06) : 640 - 642
  • [6] DIAGNOSIS OF INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    PHAIR, JP
    WOLINSKY, S
    CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 13 - 16
  • [7] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CHILDREN
    DOWE, DA
    HEITZMAN, ER
    LARKIN, JJ
    CLINICAL IMAGING, 1992, 16 (03) : 145 - 151
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE INTESTINE
    GRIFFIN, GE
    BAILLIERES CLINICAL GASTROENTEROLOGY, 1990, 4 (03): : 657 - 673
  • [9] THE IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    PANTALEO, G
    GRAZIOSI, C
    FAUCI, AS
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05): : 327 - 335
  • [10] NEUROSYPHILIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    WHITEFIELD, SG
    EVERETT, AS
    REIN, MF
    JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03): : 609 - 609